Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

12-15 November, 2019
RAI Amsterdam,
Amsterdam, Netherlands

Improve delivery and drive products to market through expert insight, new data and technology for oligonucleotide therapeutics

TIDES Europe 2018 was a success!

Thank you to all of the attendees who made this year's show the largest one yet. Mark your calendar for next year's show, held 12-15 November 2019 at the RAI in Amsterdam.

Access the 2018 Attendee List


All 2018 registered attendees have access to the 2018 attendee list through the TIDES Europe Networking App.  If you cannot locate your log-in credentials, please contact chisom.fadeyi@knect365.com.

The App will be available through the end of the year. 

Check out the topics that were covered at the 2018 meeting

R&D Strategies & Delivery
  • Stay on top of new techniques for improved delivery beyond the liver
  • Discover the latest design approaches to produce stereo defined oligonucleotides
  • Explore next generation R&D strategies and innovative chemistries
Manufacturing & Scale Up
  • Delve into strategies to reduce cost of goods and improve manufacturing efficiency
  • Master process development and scale up of complex oligonucleotide therapeutics
  • Discover how enzyme catalysed assembly and liquid phase synthesis can be applied to large scale production
Preclinical & Clinical
  • What are the most exciting oligonucleotides advancing through the clinic?
  • Get top tips learnt from preclinical and clinical development
  • Examine approaches to extend oligonucleotide products to mass markets
CMC & Analytical Methods
  • Uncover analytical methods to identify and characterise oligonucleotide impurities
  • Learn how industry are developing CMC control strategies
  • Understand how mass spectrometry can be applied for product characterisation
mRNA & CRISPR
  • Hear the latest preclinical and clinical developments
  • Overcome the delivery challenges for mRNA and CRISPR therapeutics
  • Tackle analytical method development, scale up and large-scale manufacturing
Keynotes
  • RNAi Therapeutics Delivered: From Principles to Patients
    • Muthiah (Mano) Manoharan, Alnylam Pharmaceuticals, Inc.
  • Antisense Therapeutics Successes in High Unmet Need Diseases
    • Steve Hughes, Ionis Pharmaceuticals

Gain the Science, Technologies and Contacts You Need to Accelerate Peptide Therapeutics to Market

300+
OLIGONUCLEOTIDE AND PEPTIDE SCIENTISTS AND EXECUTIVES
40+
CASE STUDIES AND NEW DATA PRESENTATIONS
30+
LEADING EXHIBITORS

Thank you to our EuroTIDES 2018 Scientific Advisory Board

  • Muthiah (Mano) Manoharan, Senior VP, Drug Discovery, Alnylam Pharmaceuticals, Inc, USA
  • Yogesh Sanghvi, President, Rasayan, USA
  • Troels Koch, VP & Head of Research, RNA Therapeutics, Roche Innovation Center Copenhagen A/S, Denmark
  • Thomas Rupp, Owner, Thomas Rupp Consulting, Germany
  • Professor Cy Stein, Department of Medical Oncology and Experimental Therapeutics, City of Hope Medical Center, USA
  • Mike Gait, MRC Programme Leader, MRC Laboratory of Molecular Biology, UK
  • Dmitry Samarsky, Oligonucleotide (RNAi) Technology and Therapeutics, Experienced Executive and Industry Expert

PARTNERING OPPORTUNITIES FOR EUROTIDES 2019


Highlight your company's expertise to 300+ scientists and key decision makers working across peptide & oligonucleotide development.  A wide variety of options are available to accommodate your company's goals and budget.